DFDADECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

Adalimumab

Treatment used for 5 conditions

Total Trials
620
Total Participants
161K
Avg Effectiveness
76%
Avg Safety Score
49%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.

Rheumatoid arthritis
Effectiveness:82%
Safety:42%
Trials:249
Participants:75K
Ankylosing Spondylitis
Effectiveness:65%
Safety:60%
Trials:68
Participants:30K
Psoriasis
Effectiveness:75%
Safety:52%
Trials:175
Participants:30K
Crohn's Disease
Effectiveness:75%
Safety:45%
Trials:124
Participants:25K
Pyoderma
Effectiveness:85%
Safety:48%
Trials:4
Participants:1K
DECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

EVIDENCE-BASED TREATMENT INFORMATION

TREATMENTS

  • CONDITIONS
  • TREATMENTS
  • FIND TRIALS

ABOUT

  • ABOUT
  • RESEARCH & EVIDENCE
  • FAQ

CONTACT

hello@dfda.earth
dFDA.earth

EVIDENCE-BASED TREATMENT INFORMATION

PRIVACY POLICY•TERMS OF SERVICE
© 2025 Mike P. Sinn